BioVex Group, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BioVex Group, Inc.
Exec Chat: Butterfly Network Brings Maternal Ultrasound To Underserved Regions
Medtech Insight talked to Sachita Shah, Butterfly Network's director of global health, and John Martin, the company's chief medical officer, to learn more about how point-of-care ultrasound can benefit rural, underserved communities in Sub-Saharan Africa by helping to reduce maternal mortality and childbirth-related complications.
Scrip Asks...What Does 2023 Hold For Biopharma? Part 1: The Funding Environment
With valuations down and borrowing costs up, many industry insiders are expecting Darwinian scenes in biotech this year. Survival of the fittest is the order of the day: companies with riskier, less commercially defined propositions will struggle, while platform companies with multiple shots on strong goals will increasingly find favor in a more risk-averse environment.
Digital Health Roundup: Telehealth Strong, Diabetes Recalls And Expansions, AI And Radiology
In this month’s Digital Health Roundup, Medtech Insight’s Reed Miller offers a recap from the recent TCT 2022 meeting and talks about Butterfly Network’s expansion into Africa while Marion Webb highlights her interview with Aidoc’s CEO Elad Walach discussing plans for the AI-based software company.
Minute Insight: Butterfly Deploys POC Ultrasound In Kenya To Support New Mothers
The company received a $5m grant from the Bill & Melinda Gates Foundation to improve access to medical imaging across Sub-Saharan Africa.
- Gene Therapy, Cell Therapy
- Large Molecule
Drug Discovery Tools
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.